These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 25841466)

  • 1. On independent data monitoring committees in oncology clinical trials.
    Wittes J; Schactman M
    Chin Clin Oncol; 2014 Sep; 3(3):40. PubMed ID: 25841466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance and role of independent data monitoring committees (IDMCs) in oncology clinical trials.
    Schöffski P
    BMJ Open; 2021 Oct; 11(10):e047294. PubMed ID: 34697110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Forming your phase III trial's data and safety monitoring board: a perspective on safety.
    Wittes J
    J Investig Med; 2004 Nov; 52(7):453-8. PubMed ID: 15651261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reports to Independent Data Monitoring Committees: An Appeal for Clarity, Completeness, and Comprehensibility.
    Buhr KA; Downs M; Rhorer J; Bechhofer R; Wittes J
    Ther Innov Regul Sci; 2018 Jul; 52(4):459-468. PubMed ID: 29714543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding the functions and operations of data monitoring committees: Survey and focus group findings.
    Calis KA; Archdeacon P; Bain RP; Forrest A; Perlmutter J; DeMets DL
    Clin Trials; 2017 Feb; 14(1):59-66. PubMed ID: 27885056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Data and safety monitoring policy for National Institute of Allergy and Infectious Diseases clinical trials.
    Dixon DO; Weiss S; Cahill K; Fox L; Love J; McNamara J; Soto-Torres LE
    Clin Trials; 2011 Dec; 8(6):727-35. PubMed ID: 22024105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Independent data monitoring committees: preparing a path for the future.
    Hess CN; Roe MT; Gibson CM; Temple RJ; Pencina MJ; Zarin DA; Anstrom KJ; Alexander JH; Sherman RE; Fiedorek FT; Mahaffey KW; Lee KL; Chow SC; Armstrong PW; Califf RM
    Am Heart J; 2014 Aug; 168(2):135-41.e1. PubMed ID: 25066551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the data safety and monitoring board in an international trial.
    NIMH Collaborative HIV/STD Prevention Trial
    AIDS; 2007 Apr; 21 Suppl 2():S99-102. PubMed ID: 17413269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Independent data monitoring committees: an update and overview.
    Sartor O; Halabi S
    Urol Oncol; 2015 Mar; 33(3):143-8. PubMed ID: 25631301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lessons learned from independent central review.
    Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
    Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A safety monitoring procedure for a clinical drug development program, with application to the assessment of a novel COX-2 inhibitor.
    Bolland K; Whitehead J; Oldham M
    J Biopharm Stat; 2008; 18(4):737-49. PubMed ID: 18607805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring participant safety in phase I and II interventional trials: options and controversies.
    Hibberd PL; Weiner DL
    J Investig Med; 2004 Nov; 52(7):446-52. PubMed ID: 15651260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethical pitfalls in neonatal comparative effectiveness trials.
    Modi N
    Neonatology; 2014; 105(4):350-1. PubMed ID: 24931328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guidelines for data and safety monitoring for clinical trials not requiring traditional data monitoring committees.
    ; Dixon DO; Freedman RS; Herson J; Hughes M; Kim K; Silverman MH; Tangen CM
    Clin Trials; 2006; 3(3):314-9. PubMed ID: 16895048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recommendations for data monitoring committees from the Clinical Trials Transformation Initiative.
    Calis KA; Archdeacon P; Bain R; DeMets D; Donohue M; Elzarrad MK; Forrest A; McEachern J; Pencina MJ; Perlmutter J; Lewis RJ
    Clin Trials; 2017 Aug; 14(4):342-348. PubMed ID: 28503947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Building a more connected DSMB: better integrating ethics review and safety monitoring.
    Eckstein L
    Account Res; 2015; 22(2):81-105. PubMed ID: 25397600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the independence of data monitoring committee in adaptive design clinical trials.
    Chow SC; Corey R; Lin M
    J Biopharm Stat; 2012; 22(4):853-67. PubMed ID: 22651119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [DSMB. 1. What role, what responsibilities?].
    Brun-Buisson C
    Med Sci (Paris); 2005 Jan; 21(1):78-82. PubMed ID: 15639025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.